MYX.AX - Mayne Pharma Group Limited

ASX - ASX Delayed price. Currency in AUD
1.245
-0.025 (-1.97%)
At close: 4:10PM AEST
Stock chart is not supported by your current browser
Previous close1.270
Open1.270
Bid1.220 x 0
Ask1.270 x 0
Day's range1.230 - 1.280
52-week range0.590 - 1.425
Volume10,719,658
Avg. volume7,893,801
Market cap1.958B
Beta1.07
PE ratio (TTM)N/A
EPS (TTM)-0.092
Earnings date19 Feb. 2018 - 23 Feb. 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend date2011-03-03
1y target est1.18
  • Federal Court approves Sirtex Medical Limited (ASX:SRX) takeover: Where I would reinvest these funds
    Motley Fool11 days ago

    Federal Court approves Sirtex Medical Limited (ASX:SRX) takeover: Where I would reinvest these funds

    The Sirtex Medical Limited (ASX:SRX) share price pushed higher on Wednesday after the Federal Court approved the takeover by CDH Genetech and China Grand Pharmaceutical and Healthcare. What now?

  • What Does Mayne Pharma Group Limited’s (ASX:MYX) Ownership Structure Look Like?
    Simply Wall St.17 days ago

    What Does Mayne Pharma Group Limited’s (ASX:MYX) Ownership Structure Look Like?

    Today, I will be analyzing Mayne Pharma Group Limited’s (ASX:MYX) recent ownership structure, an important but not-so-popular subject among individual investors. The impact of a company’s ownership structure affects bothRead More...

  • 3 healthcare stars I want in my portfolio
    Motley Fool24 days ago

    3 healthcare stars I want in my portfolio

    Forget Ramsay Health Care Limited (ASX:RHC) shares and snap up one of these three healthcare stars...

  • Leading brokers name 3 ASX shares to buy today
    Motley Fool27 days ago

    Leading brokers name 3 ASX shares to buy today

    Westpac Banking Corp (ASX:WBC) shares are one of three named by leading brokers as the ones to buy this week...

  • Mayne Pharma Group Ltd (ASX:MYX) shares rocket 14% higher on solid results
    Motley Foollast month

    Mayne Pharma Group Ltd (ASX:MYX) shares rocket 14% higher on solid results

    The Mayne Pharma Group Ltd (ASX:MYX) share price has rocketed 14% higher to $1.20 following the release of its full year results...

  • Mayne Pharma Group Limited (ASX:MYX): Time For A Financial Health Check
    Simply Wall St.3 months ago

    Mayne Pharma Group Limited (ASX:MYX): Time For A Financial Health Check

    Mayne Pharma Group Limited (ASX:MYX) is a small-cap stock with a market capitalization of AU$1.32b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...

  • Best ASX Growth Companies
    Simply Wall St.3 months ago

    Best ASX Growth Companies

    Companies such as Propel Funeral Partners and Jumbo Interactive have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolio shouldRead More...

  • Mayne Pharma expects "soft" H1 to improve
    AAP10 months ago

    Mayne Pharma expects "soft" H1 to improve

    Drugs manufacturer Mayne Pharma is still feeling the impact of tough competition and lower prices in the generic drugs market in the US, but expects the release of new drugs and restructuring initiatives will boost the company's financial performance. Chief executive Scott Richards says the company's first half is expected to be "soft" but that a range of initiatives is already yielding benefits. Shares in Mayne Pharma dropped 1.5 cents, or 2.4 per cent, to 61 cents.

  • AAP10 months ago

    Mayne Pharma warns of 'soft' first half

    Mayne Pharma's revenue for the first four months of the financial year dropped 12 per cent due to price deflation in the US generic marketplace. Chief executive Scott Richards says group revenue to the ...